Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 17/20 | 0.47 |
| ▸ | PTGER3 | P43115 | 7/20 | 0.46 |
| ▸ | PTGER2 | P43116 | 6/20 | 0.43 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6162531 | 0.88 | PTGER4 (0.57) | PTGER4PTGER3PTGER2PTGER1 | |
| SCHEMBL6162536 | 0.88 | PTGER4 (0.57) | PTGER4PTGER3PTGER2PTGER1 | |
| SCHEMBL14775911 | 0.85 | PTGER4 (0.56) | PTGER4PTGER3PTGER2PTGER1 | |
| SCHEMBL6717447 | 0.85 | PTGER4 (0.56) | PTGER4PTGER3PTGER2PTGER1 | |
| SCHEMBL6717439 | 0.85 | PTGER4 (0.56) | PTGER4PTGER3PTGER2PTGER1 | |
| SCHEMBL6711603 | 0.84 | PTGER4 (0.59) | PTGER4PTGER3PTGER2P2RX7ALDH1A1 | |
| SCHEMBL6694775 | 0.84 | PTGER4 (0.59) | PTGER4PTGER3PTGER2P2RX7ALDH1A1 | |
| SCHEMBL14775797 | 0.81 | P2RX7 (0.43) | PTGER4PTGER3PTGER2P2RX7KDM4E | |
| SCHEMBL15033731 | 0.81 | PTGER4 (0.53) | PTGER4PTGER3PTGER2PTGER1 | |
| SCHEMBL4987037 | 0.81 | PTGER4 (0.46) | PTGER4PTGER3PTGER2PTGER1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1503984-B1 | 8-AZAPROSTAGLANDIN ANALOGS AS AGENTS FOR LOWERING INTRAOCULAR PRESSURE | ALLERGAN INC (US) | 2013-03-20 | — | — | EP | claimed |